NEISVAC-C

This brand name is authorized in Austria, Canada, Cyprus, Estonia, Spain, France, Ireland, Lithuania, Malta, Netherlands, New Zealand, Poland

Active ingredients

The drug NEISVAC-C contains one active pharmaceutical ingredient (API):

1 Meningococcal group C (oligosaccharide conjugate to diphtheria CRM197 protein) UNII H2W22AGF1P - NEISSERIA MENINGITIDIS GROUP C CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN

Read about Meningococcal group C conjugate vaccine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07AH07	Meningococcus C, purified polysaccharides antigen conjugated	J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AH Meningococcal vaccines
Discover more medicines within J07AH07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02245057
Country: EE	Ravimiamet	Identifier(s): 1355767, 1355778
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 64096
Country: FR	Base de données publique des médicaments	Identifier(s): 69261547
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1009819, 1037215, 1037216
Country: MT	Medicines Authority	Identifier(s): MA505/07801
Country: NL	Z-Index G-Standaard	Identifier(s): 14686104
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 62235
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 11388
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100216990